Novartis AG;The Trustees of the University of Pennsylvania
发明人:
Glenn Dranoff
申请号：
US16082035
公开号：
US20200281973A1
申请日:
2017.03.03
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The invention provides compositions and methods for treating diseases associated with expression of a tumor antigen as described herein by administration of a cell comprising a chimeric antigen receptor that binds a B-Cell antigen and a chimeric antigen receptor which binds a tumor antigen.
